Company Overview
BNB Plus Corp. operates within the financial services sector, specifically focusing on the asset management industry where it provides digital asset treasury services alongside real-time data tracking of treasury performance and market indicators. Through its subsidiaries, the entity also engages in the development and commercialization of technologies designed to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid. The company maintains a modest operational scale with a current market capitalization of $3.76M, annual revenue of $1.83M, and an employee base of 26 individuals. These valuation and revenue figures indicate that BNB Plus Corp. is a small-cap entity with limited revenue generation relative to its market presence, suggesting a niche operational footprint rather than broad market dominance. The combination of digital asset services and biotechnology technology development positions the firm at the intersection of financial services and specialized scientific innovation, though the small market cap implies significant volatility and limited liquidity compared to larger peers.
Financial Health
The company reported a revenue of $1.83M for the trailing twelve months, yet this generated a net income of $-70,157,456 and an EBITDA of $-28,339,856. The substantial gap between the positive revenue of $1.83M and the deeply negative net income reveals a highly aggressive cost structure or significant one-time charges that erode profitability despite top-line activity. Free cash flow stands at $-17,404,216, indicating that the company is currently burning cash and lacks the immediate financial flexibility to fund operations without external capital injections. The gross margin is 29.9%, which suggests that the company retains a nearly 30% portion of sales after direct costs, while the operating margin of -3248.8% and profit margin of 0.0% highlight severe operational inefficiencies or extraordinary expenses that prevent the company from converting revenue into operating profit. On the balance sheet, the company holds $2.45M in cash against $48,861 in debt, resulting in a debt-to-equity ratio of 0.27, which points to a conservative leverage position where equity significantly outweighs liabilities. The current ratio of 2.32 indicates that the company possesses 2.32 times the current assets necessary to cover its short-term obligations, suggesting adequate short-term liquidity despite the cash burn. Return on Equity is -199.1% and Return on Assets is -98.0%, metrics that reveal management is currently destroying shareholder value and failing to generate returns on the capital deployed to run the business.
Valuation Assessment
The trailing P/E ratio is 0.00 while the forward P/E is N/A, a disparity that implies the company has no earnings to value against current stock price and that future earnings estimates are unavailable or non-existent for valuation purposes. The price-to-book ratio is 0.17, indicating that the market values the company at less than one-fifth of its book value, which suggests significant market skepticism regarding the quality of its assets or the realization of its intangible technology value. Alternative valuation metrics include a price-to-sales ratio of 2.05 and an EV/EBITDA of -0.04, figures that suggest the stock is trading at a premium relative to sales despite being unprofitable, a common characteristic of speculative growth or turnaround plays that investors may be pricing for future recovery. The stock has experienced extreme volatility within its trading range, with a 52-week high of $35.85 and a 52-week low of $0.61. Based on the provided data, the current trading environment reflects high uncertainty, though without a specific current price listed in the facts, the range demonstrates a massive potential swing from lows near 0.61 to highs near 35.85. The beta value is 0.69, which indicates that the stock is less volatile than the broader market, moving at roughly 31% less intensity than the benchmark, yet this lower volatility is often observed in small-cap stocks that are frequently illiquid.
Growth & Income
Revenue growth year-over-year is -35.0%, while earnings growth is N/A due to the lack of comparable prior earnings data, making it impossible to determine if earnings are growing faster or slower than revenue at this specific point in time. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the entity retains all its earnings or losses rather than distributing income to shareholders. As a non-dividend payer, the company theoretically reinvests any available resources or seeks to grow through operations, though the negative free cash flow limits the ability to fund internal expansion without external financing. The overall growth and income profile is characterized by significant revenue contraction and an absence of income distribution, reflecting a firm in a stage of development or distress where capital preservation is likely the primary focus rather than income generation or expansion.